QCM Cayman’s Acadia Healthcare ACHC Stock Holding History

QCM Cayman’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-8,667	Closed	-$223K	–	41
2018 Q4	$223K	Buy	+8,667	New	+$300K	0.91%	51

Other funds holding ACHC

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return

QCM Cayman's ACHC Position: Q1 2019 in Review

QCM Cayman sold out of Acadia Healthcare (ACHC) in Q1 2019, closing a stake of 8,667 shares — an estimated $223K sold.

QCM Cayman first reported a position in ACHC in Q4 2018 and held it in 1 quarter. The position peaked at $223K in Q4 2018. 255 funds tracked by Wall St. Rank hold ACHC as of Q1 2019.

QCM Cayman reported no remaining Acadia Healthcare position as of Q1 2019 after selling out during the quarter.
QCM Cayman sold 8,667 Acadia Healthcare shares in Q1 2019, an estimated $223K.
QCM Cayman first reported a position in Acadia Healthcare in Q4 2018 and held it in 1 quarter.
QCM Cayman's Acadia Healthcare position peaked at $223K in Q4 2018.
255 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2019.

Based on QCM Cayman's 13F filing for Q1 2019, filed 13 May 2019.